PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
41.32%
Net income growth 1.25-1.5x CRWD's 30.05%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
14.17%
D&A growth well above CRWD's 6.21%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
270.81%
Well above CRWD's 61.99% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
127.43%
SBC growth well above CRWD's 13.23%. Michael Burry would flag major dilution risk vs. competitor’s approach.
112.26%
Slight usage while CRWD is negative at -200.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
377.55%
AR growth while CRWD is negative at -124.34%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
93.81%
Growth well above CRWD's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-108.54%
Negative yoy while CRWD is 14.15%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
33.53%
Some CFO growth while CRWD is negative at -13.35%. John Neff would note a short-term liquidity lead over the competitor.
37.80%
CapEx growth well above CRWD's 64.44%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-732.72%
Negative yoy acquisition while CRWD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
15.46%
Less growth in investment purchases vs. CRWD's 31.64%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-4.81%
Both yoy lines are negative, with CRWD at -36.63%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
167.59%
We have some outflow growth while CRWD is negative at -9.26%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-309.95%
We reduce yoy invests while CRWD stands at 52.10%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
111.50%
We slightly raise equity while CRWD is negative at -200.00%. John Neff sees competitor possibly preserving share count or buying back shares.
59.40%
Buyback growth of 59.40% while CRWD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.